PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZYXI vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ZYXI and XLV is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ZYXI vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zynex Inc (ZYXI) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
1.12%
0.51%
ZYXI
XLV

Key characteristics

Sharpe Ratio

ZYXI:

-0.69

XLV:

0.44

Sortino Ratio

ZYXI:

-0.81

XLV:

0.69

Omega Ratio

ZYXI:

0.90

XLV:

1.08

Calmar Ratio

ZYXI:

-0.41

XLV:

0.39

Martin Ratio

ZYXI:

-0.93

XLV:

1.04

Ulcer Index

ZYXI:

33.16%

XLV:

4.85%

Daily Std Dev

ZYXI:

45.11%

XLV:

11.37%

Max Drawdown

ZYXI:

-99.72%

XLV:

-39.17%

Current Drawdown

ZYXI:

-71.63%

XLV:

-5.71%

Returns By Period

In the year-to-date period, ZYXI achieves a 0.62% return, which is significantly lower than XLV's 6.88% return. Over the past 10 years, ZYXI has outperformed XLV with an annualized return of 54.41%, while XLV has yielded a comparatively lower 9.54% annualized return.


ZYXI

YTD

0.62%

1M

-0.37%

6M

1.13%

1Y

-31.11%

5Y*

-1.43%

10Y*

54.41%

XLV

YTD

6.88%

1M

5.81%

6M

0.51%

1Y

4.88%

5Y*

8.96%

10Y*

9.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZYXI vs. XLV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZYXI
The Risk-Adjusted Performance Rank of ZYXI is 1717
Overall Rank
The Sharpe Ratio Rank of ZYXI is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of ZYXI is 1313
Sortino Ratio Rank
The Omega Ratio Rank of ZYXI is 1515
Omega Ratio Rank
The Calmar Ratio Rank of ZYXI is 2121
Calmar Ratio Rank
The Martin Ratio Rank of ZYXI is 2525
Martin Ratio Rank

XLV
The Risk-Adjusted Performance Rank of XLV is 1818
Overall Rank
The Sharpe Ratio Rank of XLV is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of XLV is 1717
Sortino Ratio Rank
The Omega Ratio Rank of XLV is 1717
Omega Ratio Rank
The Calmar Ratio Rank of XLV is 2222
Calmar Ratio Rank
The Martin Ratio Rank of XLV is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZYXI vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zynex Inc (ZYXI) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZYXI, currently valued at -0.69, compared to the broader market-2.000.002.004.00-0.690.44
The chart of Sortino ratio for ZYXI, currently valued at -0.81, compared to the broader market-4.00-2.000.002.004.00-0.810.69
The chart of Omega ratio for ZYXI, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.08
The chart of Calmar ratio for ZYXI, currently valued at -0.41, compared to the broader market0.002.004.006.00-0.410.39
The chart of Martin ratio for ZYXI, currently valued at -0.93, compared to the broader market-10.000.0010.0020.0030.00-0.931.04
ZYXI
XLV

The current ZYXI Sharpe Ratio is -0.69, which is lower than the XLV Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of ZYXI and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
-0.69
0.44
ZYXI
XLV

Dividends

ZYXI vs. XLV - Dividend Comparison

ZYXI has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.56%.


TTM20242023202220212020201920182017201620152014
ZYXI
Zynex Inc
0.00%0.00%0.00%0.72%0.00%0.00%0.00%2.38%0.00%0.00%0.00%90.91%
XLV
Health Care Select Sector SPDR Fund
1.56%1.67%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%

Drawdowns

ZYXI vs. XLV - Drawdown Comparison

The maximum ZYXI drawdown since its inception was -99.72%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for ZYXI and XLV. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-71.63%
-5.71%
ZYXI
XLV

Volatility

ZYXI vs. XLV - Volatility Comparison

Zynex Inc (ZYXI) has a higher volatility of 11.30% compared to Health Care Select Sector SPDR Fund (XLV) at 3.99%. This indicates that ZYXI's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
11.30%
3.99%
ZYXI
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab